top of page

NEWS AND UPDATES FROM LEP BIOMEDICAL 

22/11/24 LEP BIOMEDICAL PRESENT AT OIS XIV IN SAN DIEGO, USA.

ois_edited.jpg

The 14th Ophthalmology Innovation Summit (OIS) took place in the Hard Rock Hotel in San Diego from Nov 22-23. During which, CEO Alan Hibbitts gave a 7 minute overview of LEP Biomedical to a sold out summit of clinical and industrial field leaders.

​

OIS:

"Connecting clinical, corporate, and capital leaders to drive the ophthalmic market forward. This two-day event will showcase groundbreaking advancements and clinical insights in both anterior and posterior ophthalmology segments and promises unmatched learning, networking, and collaboration."

21/11/24 LEP BIOMEDICAL WIN SILVER IN MEDTECH AT THE FINALS OF THE NATIONAL START-UP AWARDS 2024 IN DUBLIN, IRELAND.

LEP Biomedical were delighted to win silver at the finals of the National Start Up Awards 2024.

​

Placed in the MedTech category, LEP Biomedical progressed through a long- and short-listing process prior to an in-person pitch against seven finalist companies.

​

We are delighted to see a glaucoma-focused company achieve such recognition in an open MedTech category!

​

Congratulations to all competitors and thanks to the organizers!

05/09/24 LEP BIOMEDICAL PRESENT AT OPHTHALMOLOGY FUTURES FORUM IN BARCELONA, SPAIN.

OFF 1_edited.jpg

CEO Alan Hibbitts and CMO Prof. Colm O’Brien presented HyaGuard™ to a range of clinical and industrial stakeholders including C-suite level members of key strategics in Spain at Esferic, Barcelona.

 

Ophthalmology Futures Forums are clinician-driven innovation meetings focusing on new technology, entrepreneurial ventures, market access, and other aspects of commercialisation in the ophthalmic healthcare sector.

OFF 2_edited.jpg

01/06 - 04/06/24 LEP BIOMEDICAL PRESENT AT 16TH EUROPEAN GLAUCOMA SOCIETY IN DUBLIN, IRELAND.

EGS_2024.jpg

CEO Alan Hibbitts and CMO Prof. Colm O’Brien presented HyaGuard™ to a range of clinical and industrial stakeholders at the European Glaucoma Congress 2026.

 

This biennial event gathered over 2500 leading glaucoma specialists for four days of meetings, idea exchange and patient advocacy. Throughout, there was a consistent appetite present for better outcomes and tangible improvements for both patient and surgeon alike.

29/05/24 LEP BIOMEDICAL PROGRESS TO FINAL 3 OF INNOVATION AWARD AT FUTURE HEALTH SUMMIT 2024, DUBLIN IRELAND.

Future_Health_Summit_2024.jpg

Following a record number of applications, LEP Biomedical were successful in progressing to the final 8 HealthTech start-ups on Day 1 of the Future Health Summit 2024 in Dublin, Ireland.

 

After a 90-second pitch competition, LEP Biomedical then progressed to the final 3 companies for panel interviews with journalist Andy O'Donoghue.

​

It was our great privilege to showcase our HyaGuard™ platform for enhanced glaucoma surgical outcomes not once but twice to over 500 healthcare and hospital management professionals. Our mantra of “value to all stakeholders” was more relevant than ever.

Congrats to fellow finalist Cymantic Medical and especially to winner Intheliatx!

O4/04/24 LEP BIOMEDICAL FUNDING ANNOUNCED IN MARKETSCOPE AND EYEWIRE+ PUBLICATIONS.

Building on initial momentum following the announcement of their pre-seed funding, LEP Biomedical has also received further publicity in major market evaluation outlets MarketScope and Eyewire+.

​

Links to both articles can be found below:

​

MarketScope

​

Eyewire+

MarketScope_logo.png
Untitled-4.jpg
EI Logo.jpg

05/03/24 LEP Biomedical Ltd closes initial Pre-Seed Investment with Enterprise Ireland.

LEP Biomedical is delighted to announce the finalisation of pre-seed funding through Enterprise Ireland and the Pre-Seed Start Fund!

 

This investment of €100,000 over two 6-month periods provides runway to full seed investment and allows essential regulatory affairs and reimbursement work.

 

LEP Biomedical is grateful for Enterprise Ireland’s continued support as we continue our mission to ensure glaucoma surgery outcomes through our proprietary HyaGuard™ platform.

04/12/23 LEP BIOMEDICAL COMPLETE PIONEER GROUP ACCELERATOR PROGRAMME

PIONEER-GROUP.jpg

Following a competitive selection process, LEP Biomedical participated in UK-based venture
builder Pioneer Group’s accelerator programme. Taking place online and at their Dublin
location in the Cherrywood campus over eight weeks, significant progress was made in end-
user feedback and customer workflow.

​

Accelerator Programme - Pioneer Group

​

Well done to all participants as they continue to scale and grow!

Griffith College.jpg

Pictured: (From left) Jennifer Osuji, Michael-Philippe Bosonnet, Alan Hibbitts and Laura Becerra.

01/12/23 LEP Biomedical draft initial sustainability charter with Griffith College Ireland’s Graduate Business School.

LEP Biomedical is delighted to finalise their initial sustainability charter. Underpinned by the motto, “Sustainability by Design”, a draft charter has been created to identify early how LEP Biomedical will ensure a cleaner, more equitable world.


Many thanks to Laura Becerra, Jennifer Osuji and Michael-Philippe Bosonnet of Griffith College Graduate Business School for their tireless work and input on this project. 

IDEATE_photo.jpg

Pictured: LEP Biomedical CEO Dr. Alan Hibbitts and LEP Biomedical Researchers Dr Golestan Salimbeigi, and Dr Tauseef Ahmad.

20/06/23 LEP Biomedical Awarded 1st Runner up at IDEATE Ireland Accelerator.

Following initial selection from over 80 applicants and a 10-week intensive accelerator programme, LEP Biomedical are thrilled to be awarded 1st runner-up following the final showcase and pitch day competition. All companies presented incredibly promising concepts and with collaboration and support fostered throughout.

 

Congratulations to 1st place winners ArrayPatch, Third Place Joint-Awardees Re-Coli and Sision Medical, and all companies and sponsors. Special thanks also to the IDEATE co-founder and leader of the programme Helen Fullen.

​

Ideate Ireland - Empowering Entrepreneurs

16/05/23 LEP Biomedical at BioEquity Europe in Dublin, Ireland

CEO Dr. Alan Hibbitts and LEP Biomedical Scientist Dr. Golestan Salimbeigi presented the HyaGuard technology and development timeline at both an oral and poster presentation at Bioequity Europe. This was LEP Biomedical's largest audience to date and was made possible through generous support from the Office of Research and Innovation at The Royal College of Surgeons in Ireland.

MTI_edited.jpg

24/04/23 LEP Biomedical at the MedTech Innovator Roadshow in Dublin, Ireland

Dr. Ronan MacLoughlin and Dr. Tauseef Ahmad had the opportunity to engage with global KOLs as part of LEP Biomedical's mission to raise awareness of its proprietary HyaGuard technology.

30/01/23 LEP Biomedical at Bioengineering in Ireland

Congratulations to LEP Biomedical researcher  Dr. Tauseef Ahmad for winning "Best Medical Device Research Oral Presentation" at the Annual Bioengineering in Ireland meeting at Johnstown House, Enfield, Co. Meath.

​

Dr. Ahmad gave a highly impactful overview of the foundation and validation of the HyaGuard Technology.

bottom of page